A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

OBJECTIVE: Rheumatoid arthritis (RA) is associated with increased cardiovascular event (CVE) risk. The impact of statins in RA is not established. We assessed whether atorvastatin is superior to placebo for the primary prevention of CVEs in RA patients. METHODS: A randomized, double‐blind, placebo‐c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitas, George D., Nightingale, Peter, Armitage, Jane, Sattar, Naveed, Belch, Jill J. F., Symmons, Deborah P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771601/
https://www.ncbi.nlm.nih.gov/pubmed/30983166
http://dx.doi.org/10.1002/art.40892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771601/
https://www.ncbi.nlm.nih.gov/pubmed/30983166
http://dx.doi.org/10.1002/art.40892

Ejemplares similares